Unsupervised clustering in a cohort of biopsy-proven MASLD patients revealed a subgroup with hepatic ferroptosis signature and lower glutathione peroxidase 4 (GPX4) levels. The gene discussed is GPX4; the disease is metabolic dysfunction-associated steatotic liver disease.